重药控股净利三年连降资产负债率75% 涉诉约11.64亿元应收账款超329亿元

Group 1 - The company, Zhongyao Holdings, is currently embroiled in litigation, with a total of approximately 1.164 billion yuan involved in lawsuits and arbitration over the past twelve months, which accounts for 10.28% of the company's latest audited net assets attributable to the parent company [1][2] - The company has seen continuous revenue growth from 2022 to 2024, with revenues of 67.829 billion yuan, 80.119 billion yuan, and 80.562 billion yuan respectively, marking a consistent increase [3] - However, the net profit attributable to the parent company has declined over the same period, with figures of 0.952 billion yuan, 0.625 billion yuan, and 0.283 billion yuan, reflecting a year-on-year decrease of 5.29%, 34.41%, and 54.69% respectively [3] Group 2 - The company has faced significant credit impairment losses, which were 0.104 billion yuan, 0.440 billion yuan, and 0.524 billion yuan from 2022 to 2024, indicating issues with accounts receivable collection [3] - Financial expenses have also impacted net profit, with expenses of 1.094 billion yuan, 1.302 billion yuan, and 1.084 billion yuan over the same period, highlighting substantial financial pressure [3] - As of the end of 2024, the company's debt ratio stood at 75.29%, with monetary funds of 9.392 billion yuan and interest-bearing liabilities of 23.189 billion yuan [3] Group 3 - The company has consistently distributed cash dividends from 2021 to 2024, with dividends of 0.183 billion yuan, 0.104 billion yuan, 0.0864 billion yuan, and 0.104 billion yuan, and dividend payout ratios of 18.21%, 10.89%, 13.19%, and 36.64% respectively [4] - In the first quarter of this year, the company reported a recovery in operating performance, with revenues and net profits attributable to the parent company of 20.612 billion yuan and 0.125 billion yuan, reflecting year-on-year growth of 5.03% and 21.63% [4] - As of July 2, the company's market capitalization was 8.641 billion yuan, with projected revenues exceeding 80 billion yuan for 2024 [5]